Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ichiro Yokomura is active.

Publication


Featured researches published by Ichiro Yokomura.


European Journal of Radiology | 2001

Spiral CT findings in septic pulmonary emboli

Yoshinobu Iwasaki; Kazuhiro Nagata; Masaki Nakanishi; Atushi Natuhara; Hidehiko Harada; Yutaka Kubota; Ichiro Yokomura; Shinichi Hashimoto; Masao Nakagawa

OBJECTIVES The aim of the study was to determine the characteristics of septic pulmonary emboli and their prevalence on spiral computed tomographic (CT) scans. METHODS AND MATERIALS We evaluated 65 lesions on spiral CT scans in ten patients with septic pulmonary emboli. Spiral CT scans (10-mm collimation) were obtained at 10-mm intervals from the lung apex to the diaphragm and were compared with posteroanterior chest radiographs obtained within 24 h after CT scanning. RESULTS Only 21 (32%) of the 65 lesions detected on CT scans were also detected on chest radiographs. Peripheral nodules (39 lesions (60%)) were seen in all ten patients, wedge-shaped peripheral lesions (15 lesions (23%)) in nine patients, and infiltrates (11 lesions (17%)) in four patients. Subpleural lesions (45 lesions (69%)) and feeding vessels (35 (54%)) were found in all patients, and cavitary lesions (seven lesions (11%)) were seen in four patients. Subpleural peripheral nodules and wedge-shaped peripheral lesions were seen in nine patients. Thirty-two lesions (49%) ranged in diameter from 10 to 19 mm, and 59 lesions (91%) were less than 30 mm. CONCLUSIONS Spiral CT is useful in detecting septic pulmonary emboli. On spiral CT subpleural peripheral nodules and wedge-shaped peripheral lesions less than 30 mm in diameter are often found in patients with septic pulmonary emboli.


Experimental Lung Research | 2001

ROLE OF INTERCELLULAR ADHESION MOLECULE 1 IN ACUTE LUNG INJURY INDUCED BY CANDIDEMIA

Ichiro Yokomura; Yoshinobu Iwasaki; Kazuhiro Nagata; Masaki Nakanishi; Atsushi Natsuhara; Hidehiko Harada; Yutaka Kubota; Mikio Ueda; Tohru Inaba; Masao Nakagawa

Candidemia, a complication often affecting immunocompromised patients, is a common cause of acute lung injury. Yeast-phase Candida albicans has been shown to express a protein that is antigenically and structurally related to Mac-1. C. albicans is reported to stimulate intercellular adhesion molecule 1 (ICAM-1)expression on endothelial cells. In this study, the authors examined the role of ICAM-1 in acute lung injury induced by candidemia. The authors cultured rat pulmonary artery endothelial cells (RPAEC)and investigated the effect of anti-ICAM-1antibodies on adhesion of C. albicans to RPAEC. In addition, the authors administered anti-ICAM-1 antibodies to rats to examine the effect of the antibodies on experimentally induced candidemia. Survival rates, lung wet-to-dry (W/D) weight ratios, bronchoalveolar lavage (BAL) fluid, histopathological findings, and colony-forming units (CFUs)of lung C. albicans were examined. The adherence of C. albicans to RPAEC was significantly decreased by anti-ICAM-1 antibodies. Anti-ICAM-1 antibodies significantly increased survival, decreased lung W/D weight ratios, decreased neutrophil counts in the BAL fluid, reduced microscopic lung injury, and decreased the quantity of lung C. albicans. These results indicate that ICAM-1plays a role in adherence of C. albicans to pulmonary vascular endothelial cells, which likely leads to invasion of lung tissue by the organism.Candidemia, a complication often affecting immunocompromised patients, is a common cause of acute lung injury. Yeast-phase Candida albicans has been shown to express a protein that is antigenically and structurally related to Mac-1. C. albicans is reported to stimulate intercellular adhesion molecule 1 (ICAM-1) expression on endothelial cells. In this study, the authors examined the role of ICAM-1 in acute lung injury induced by candidemia. The authors cultured rat pulmonary artery endothelial cells (RPAEC) and investigated the effect of anti-ICAM-1 antibodies on adhesion of C. albicans to RPAEC. In addition, the authors administered anti-ICAM-1 antibodies to rats to examine the effect of the antibodies on experimentally induced candidemia. Survival rates, lung wet-to-dry (W/D) weight ratios, bronchoalveolar lavage (BAL) fluid, histopathological findings, and colony-forming units (CFUs) of lung C. albicans were examined. The adherence of C. albicans to RPAEC was significantly decreased by anti-ICAM-1 antibodies. Anti-ICAM-1 antibodies significantly increased survival, decreased lung W/D weight ratios, decreased neutrophil counts in the BAL fluid, reduced microscopic lung injury, and decreased the quantity of lung C. albicans. These results indicate that ICAM-1 plays a role in adherence of C. albicans to pulmonary vascular endothelial cells, which likely leads to invasion of lung tissue by the organism.


Clinical and Vaccine Immunology | 2001

Role of Alveolar Macrophages in Candida-Induced Acute Lung Injury

Yutaka Kubota; Yoshinobu Iwasaki; Hidehiko Harada; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Masao Nakagawa

ABSTRACT Recent studies have shown that alveolar macrophages (AMs) not only act as phagocytes but also play a central role as potent secretory cells in various lung diseases, including pneumonia and acute respiratory distress syndrome. The behavior of AMs during disseminated candidiasis, however, is insufficiently elucidated. This study is the first to report disseminated candidiasis in AM-depleted mice and to analyze the effect of AMs on Candida-induced acute lung injury. While all AM-sufficient mice died by day 2 after infection withCandida albicans, no mortality was observed among AM-depleted mice. Unexpectedly, the CFU numbers of C. albicans isolated from the lungs of AM-depleted mice were significantly higher than those for C. albicans isolated from AM-sufficient mice. The lung wet-to-dry weight ratio was lower for AM-depleted mice than for AM-sufficient mice, although this difference was not significant. We found that bronchoalveolar lavage fluid (BALF) from AM-depleted mice in candidemia contained fewer neutrophils than BALF from AM-sufficient mice. In addition, myeloperoxidase activities in lung homogenates of AM-depleted mice were significantly lower than those in homogenates of AM-sufficient mice. A significant decrease in levels of murine macrophage inflammatory protein 2 (MIP-2), a potent chemoattractant for neutrophils, was noted in lung homogenates from AM-depleted mice compared with levels in homogenates from AM-sufficient mice. Immunohistochemical studies using anti-MIP-2 antibodies revealed that AMs were the cellular source of MIP-2 within the lung during candidemia. We observed that AM depletion decreased levels of AM-derived neutrophil chemoattractant, alleviated acute lung injury during candidemia, and prolonged the survival of mice in candidemia, even though clearance of C. albicans from the lungs was reduced.


Experimental Lung Research | 2005

INFLUENCE OF DEPLETION OF ALVEOLAR MACROPHAGES ON APOPTOSIS IN CANDIDA-INDUCED ACUTE LUNG INJURY

Yoshizumi Takemura; Yoshinobu Iwasaki; Kazuhiro Nagata; Ichiro Yokomura; Sou Tando; Shinji Fushiki; Hiroaki Matsubara

Apoptosis plays an important role in acute lung injury (ALI), and alveolar macrophages (AMs) are known to secrete proinflammatory cytokines and promote alveolar inflammation. The authors have previously reported that AMs can be depleted by inhalation of 1 mM 2-chloroadenosine (2-CA). In this study, the authors evaluated the effect of AM depletion by 2-CA inhalation on apoptosis in Candida-induced ALI. The results of in situ terminal deoxynucleotidyl transferase–mediated dUTP biotin nick end-labeling (TUNEL) and immunohistochemical studies and measurement of cytokine levels and caspase 3 activities in lung homogenates indicated that the Fas-FasL system and apoptosis of alveolar epithelial cells are suppressed by depletion of AMs by 2-CA inhalation.


Respiratory Medicine | 2005

Fluoroscopy-guided barium marking for localizing small pulmonary lesions before video-assisted thoracic surgery.

Yoshinobu Iwasaki; Kazuhiro Nagata; Tatsuya Yuba; Shigekuni Hosogi; Kenji Kohno; Shuji Ohsugi; Hiroomi Kuwahara; Yoshizumi Takemura; Ichiro Yokomura


Chest | 2003

Effect of Inhaled NG-Nitro-L-Arginine Methyl Ester on Candida-Induced Acute Lung Injury

Kazuhiro Nagata; Yoshinobu Iwasaki; Yoshizumi Takemura; Hidehiko Harada; Ichiro Yokomura; Shinji Fushiki; Masao Nakagawa


Clinical and Vaccine Immunology | 1999

Depletion of Alveolar Macrophages by Treatment with 2-Chloroadenosine Aerosol

Yutaka Kubota; Yoshinobu Iwasaki; Hidehiko Harada; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Masao Nakagawa


Biomedical Research-tokyo | 2007

An inhaled inducible nitric oxide synthase inhibitor reduces damage of Candida-induced acute lung injury

Shuji Ohsugi; Yoshinobu Iwasaki; Yoshizumi Takemura; Kazuhiro Nagata; Hidehiko Harada; Ichiro Yokomura; Shigekuni Hosogi; Tatsuya Yuba; Naomi Niisato; Hiroaki Miyazaki; Hiroaki Matsubara; Shinji Fushiki; Yoshinori Marunaka


The journal of the Japanese Respiratory Society | 1998

Invasive Thymoma Successfully Treated with High-Dose Chemotherapy Followed by Peripheral Blood Stem Cell Transplantation (PBSCT)

Yoshinobu Iwasaki; Yutaka Kubota; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Taichiro Arimoto; Toru Inaba; Chihiro Shimazaki; Masao Nakagawa; Shogo Toda


The journal of the Japanese Respiratory Society | 2005

[Spinal cord metastases in lung cancer: a clinical review of four cases].

Kuwahara H; Yamada T; Yuba T; Kono K; Shigekuni Hosogi; Osugi S; Kazuhiro Nagata; Ichiro Yokomura; Yoshinobu Iwasaki

Collaboration


Dive into the Ichiro Yokomura's collaboration.

Top Co-Authors

Avatar

Yoshinobu Iwasaki

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Masao Nakagawa

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinichi Hashimoto

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Mikio Ueda

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yutaka Kubota

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hidehiko Harada

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shigekuni Hosogi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuya Mizobuchi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge